Twitterに、m(メッセンジャー)RNAワクチンと変異株や接種回数の解説がありました。
新潟大学小児科Twitter
#新型コロナワクチン について
👉変異株にも効くの?
👉接種回数での変異株に対する効果の違いってあるの?
というギモンも湧くかもしれません結論からいうと、メッセンジャーRNAワクチンの場合、1回接種では変異株への効果は低いですが、2回接種では有効です💡 pic.twitter.com/5NKXiKoxaJ
— 🎗新潟大学小児科【公式】 (@Niigata_u_ped) May 30, 2021
画像
引用文献
- 1) N Engl J Med. 2020 Dec 31,383(27):2603-2615. PMID: 33301246
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – PubMed - 2) N Engl J Med. 2021 Feb 4,384(5):403-416. PMID: 33378609
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine – PubMed
- Lancet. 2021 May 15,397(10287):1819-1829. PMID: 33964222
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data – PubMed
- GOV.UK Vaccines highly effective against B.1.617.2 variant after 2 doses (preprint)
Vaccines highly effective against B.1.617.2 variant after 2 doses – GOV.UK
- 1) N Engl J Med. 2021 May 5;NEJMc2104974. PMID: 33951357
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants – PubMed - 2) GOV.UK Vaccines highly effective against B.1.617.2 variant after 2 doses (preprint)
Vaccines highly effective against B.1.617.2 variant after 2 doses – GOV.UK